Brought to you by 
GSK, Pfizer form JV, creating leading consumer health care firm; Pfizer exits JV following demerger of Haleon
02 Jun 2022
Executive Summary
GlaxoSmithKline PLC and Pfizer Inc. are combining their consumer health care businesses to create a new global leader in that sector that will be majority owned (68%) by GSK with Pfizer owning the remaining 32%.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Alliance
- Joint Venture
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
GSK, Pfizer form JV, creating leading consumer health care firm; Pfizer exits JV following demerger of Haleon
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice